Viatris VTRS Developed Markets Segment — Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Viatris in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viatris's developed markets segment — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Viatris's developed markets segment — net sales?
- Viatris (VTRS) reported developed markets segment — net sales of $2.03B in Q1 2026.
- How has Viatris's developed markets segment — net sales changed year-over-year?
- Viatris's developed markets segment — net sales increased by 6.7% year-over-year, from $1.9B to $2.03B.
- What is the long-term trend for Viatris's developed markets segment — net sales?
- Over 4 years (2021 to 2025), Viatris's developed markets segment — net sales has grown at a -4.8% compound annual growth rate (CAGR), from $10.43B to $8.55B.
- What does developed markets segment — net sales mean?
- Represents the total revenue generated from the sale of pharmaceutical products within established, high-income geographic regions. This metric reflects the market demand and pricing power of the company's portfolio in mature economies.